MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..


Company: Pharmacia & Upjohn
Approval Status: Approved July 1997
Treatment for: Parkinson's Disease
Areas: Neurology & Nervous System

| General Information |

General Information

Pramipexole was cleared for marketing in the U.S. on July 10, 1997. This is the first new anti-Parkinsonian drug to hit the market in the past six years. Pramipexole can be used to treat all stages of Parkinson's disease. Pramipexole, when given concomitantly with levodopa, improves patients with advanced Parkinson's disease and levodopa-induced motor fluctuation.

< back to top

Pramipexole Drug Information

The Pramipexole drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.